Skip to main content

PRICE T ROWE ASSOCIATES INC /MD/

Position in XERS — Xeris Biopharma Holdings, Inc.

CIK 80255 BALTIMORE, MD

Position in XERS

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$1,212,397
-$149,287 QoQ
Shares Held
209,034
+20.5% QoQ
Ownership
0.121%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2021
18 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in XERS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

PRICE T ROWE ASSOCIATES INC /MD/ holds $1,875,467,383 across 39 Drug Manufacturers - Specialty & Generic names. XERS ranks #22 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in XERS

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,212,397 209,034
2025-12-31 $1,361,684 173,463
2025-09-30 $1,357,654 166,788
2025-06-30 $715,775 153,271
2025-03-31 $968,397 176,393
2024-12-31 $577,933 170,482
2024-09-30 $458,781 160,976
2024-06-30 $294,678 130,968
2024-03-31 $277,653 125,635
2023-12-31 $270,257 115,003
2023-09-30 $209,850 112,823
2023-06-30 $289,297 110,419
2023-03-31 $200,455 122,979
2022-12-31 $163,562 122,979
2022-09-30 $161,630 103,609
2022-06-30 $56,416 36,634
2022-03-31 $61,440 24,000
2021-12-31 $37,211 12,700